TCL Archive In Brief: Revlon Foundation Gives $7.5 Million To UCA for Women’s Health Research, Breast Cancer December 16, 1994
TCL Archive Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable January 31, 2003
TCL Archive NCI declined to pay for economic, quality of life analysis in Avastin, Erbitux study. June 3, 2005
